Andrea Cavalli
The BRCA2-RAD51 interaction remains an intriguing target for cancer drug discovery due to its vital role in DNA damage repair mechanisms, which cancer cells become particularly reliant on. Moreover, RAD51 has many synthetically lethal partners, including P ...
Elsevier France-Editions Scientifiques Medicales Elsevier2024